对氯-2-[18F]氟乙基依托咪酯的辐射剂量学:一种用于肾上腺皮质显像的PET示踪剂
本研究评估了新型肾上腺皮质PET示踪剂[18F]CETO的辐射剂量学。结果显示[18F]CETO在肾上腺摄取高且5小时仍上升,男性肾上腺吸收剂量系数0.100 ± 0.032 mGy/MBq、女性0.124 ± 0.013 mGy/MBq,有效剂量系数20 µSv/MBq,典型200 MBq检查有效剂量4 mSv,认为其人体生物分布适合肾上腺显像。
要点
- [18F]CETO在肾上腺摄取高,注射后5小时仍上升。
- 肾上腺吸收剂量最高,男性0.100 ± 0.032 mGy/MBq、女性0.124 ± 0.013 mGy/MBq。
- 有效剂量系数20 µSv/MBq,200 MBq检查有效剂量4 mSv。
核心结论
- [18F]CETO在人体内具有适合肾上腺显像的生物分布。
- 典型临床PET检查使用200 MBq [18F]CETO时有效剂量为4 mSv。
研究设计与样本
- 本研究为[18F]CETO的辐射剂量学评估,临床试验注册号NCT05361083,于2022年4月29日回顾性注册。
主要发现
- [18F]CETO在肾上腺摄取高,注射后5小时仍上升。
- 肾上腺吸收剂量系数男性为0.100 ± 0.032 mGy/MBq,女性为0.124 ± 0.013 mGy/MBq,为吸收剂量最高的器官。
- 有效剂量系数为20 µSv/MBq。
关键数值与推荐
- 肾上腺吸收剂量系数:男性0.100 ± 0.032 mGy/MBq,女性0.124 ± 0.013 mGy/MBq。
- 有效剂量系数20 µSv/MBq;200 MBq [18F]CETO典型临床PET检查有效剂量4 mSv。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: [11C]metomidate, a methyl ester analogue of etomidate, is used for positron emission tomography of adrenocortical cancer, and has been tested in recent clinical trials for lateralization in primary aldosteronism (PA). However, in PA, visualization as well as uptake quantification are hampered by the tracer's rather high non-specific liver uptake, and its overall clinical usefulness is also limited by the short 20-minute half-life of carbon-11. Therefore, we evaluated para-chloro-2-[18F]fluoroethyl-etomidate, [18F]CETO, a fluorine-18 (T1/2=109.8 min) analogue, as a potential new adrenocortical PET tracer. The aim of this study was to assess radiation dosimetry of [18F]CETO. RESULTS: [18F]CETO showed a high uptake in adrenal glands, still increasing at 5 h post injection. Adrenal glands (absorbed dose coefficients 0.100 ± 0.032 mGy/MBq in males and 0.124 ± 0.013 mGy/MBq in females) received the highest absorbed dose. The effective dose coefficient was 20 µSv/MBq. CONCLUSIONS: [18F]CETO has a favourable biodistribution in humans for adrenal imaging. The effective dose for a typical clinical PET examination with 200 MBq [18F]CETO is 4 mSv. TRIAL REGISTRATION: ClinicalTrials.gov, NCT05361083 Retrospectively registered 29 April 2022. at, URL: https://clinicaltrials.gov/ct2/show/NCT05361083.
引用
- Silins I, Moreno A, Wall A, et al. Radiation dosimetry of para-chloro-2-[18F]fluoroethyl-etomidate: a PET tracer for adrenocortical imaging. EJNMMI Res. 2024. PMID: 38771379. doi:10.1186/s13550-024-01109-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。